查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1333924

前列腺素市場：現狀分析與預測（2022-2030）

Prostaglandin Market: Current Analysis and Forecast (2022-2030)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 152 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

由於前列腺素藥物的研究不斷增加，預計前列腺素市場在預測期內將以 8% 的複合年增長率增長。例如，在南裡奧格蘭德聯邦大學，比較PSLT和局部應用前列腺素類降壓滴眼液治療高眼壓或青光眼患者的效果，以達到降低眼內壓的目的。使用計算機視野測量和光療法進行。

按類型劃分，市場分為合成和天然。根據分析，合成材料領域在 2021 年獲得了主要份額。合成前列腺素通常用於治療多種疾病，包括潰瘍、青光眼和勃起功能障礙。合成前列腺素可以大量生產，這是其在前列腺素領域佔有較大份額的重要因素。

市場根據類別分為人類和獸醫產品。預計在預測期內，前列腺素市場的獸醫細分市場將以更高的複合年增長率增長。越來越多地採用寵物和牲畜以及其中慢性病的患病率不斷上升是推動獸醫行業增長的主要原因。

市場按應用細分為心血管、婦產科、眼科等。根據我們的分析，心血管領域在 2021 年獲得了主要份額。心髒病患病率的增加是心血管疾病在前列腺素市場中佔有較大份額的主要原因。例如，根據世界衛生組織 (WHO) 的統計，心血管疾病 (CVD) 是全球頭號死亡原因，每年估計奪去 1,790 萬人的生命。

為了更好地了解該行業的市場採用情況，市場分為北美（美國、加拿大、北美其他地區）、歐洲（德國、英國、法國、意大利、西班牙、歐洲其他地區）、亞太地區（中國、日本、印度、韓國、澳大利亞和亞太地區的其他國家），其他國家則根據其在世界上的存在情況進行分析。2021年前列腺素市場中，北美地區佔據壓倒性份額。這主要是由於美國等主要經濟體的存在，其中大量老年人口的存在是該地區前列腺素市場增長的關鍵因素。例如，根據社區生活管理局的數據，2019 年美國 65 歲及以上人口有 5410 萬人，其中女性 3000 萬，男性 2410 萬。

目錄

第一章 市場介紹

  • 市場定義
  • 主要目的
  • 利益相關者
  • 限制

第二章 研究方法或假設

  • 調查過程
  • 調查方法
  • 受訪者簡介

第三章市場總結

第 4 章執行摘要

第五章新型冠狀病毒感染（COVID-19）對全球前列腺素市場的影響

第六章全球前列腺素市場收入，2020-2028

第 7 章按類型劃分的市場洞察

  • 合成
  • 自然

第八章按類別劃分的市場洞察

  • 人類
  • 獸醫

第 9 章 按應用劃分的市場洞察

  • 心血管
  • 婦科手術
  • 眼科
  • 其他

第10章按地區劃分的市場洞察

  • 北美前列腺素市場
    • 美國
    • 加拿大
    • 其他北美
  • 歐洲前列腺素市場
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 歐洲其他地區
  • 亞太前列腺素市場
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 亞太地區其他國家
  • 其他地區前列腺素市場

第十一章前列腺素市場動態

  • 市場驅動力
  • 市場挑戰
  • 影響分析

第十二章前列腺素市場機會

第十三章前列腺素市場趨勢

第十四章需求側和供給側分析

  • 需求側分析
  • 供給側分析

第十五章價值鏈分析

第十六章價格分析

第十七章戰略洞察

第18章 競爭場景

  • 競爭格局
    • 波特五力分析

第十九章公司簡介

  • Sanofi
  • Cayman Chemical
  • YONSUNG Fine Chemicals Co.
  • Johnson Matthey
  • Chirogate International Inc.
  • Everlight Chemical Industrial Co.
  • Merck KGaA
  • Zhejiang Ausun Pharmaceutical Co., Ltd.
  • AspenBio
  • Pfizer Inc.

第二十章 免責聲明

簡介目錄
Product Code: UMHE212095

Prostaglandins are hormone-like substances that play a crucial role in several physiological processes such as inflammation, pain, and blood clotting. These compounds are produced naturally by the body and are also available in synthetic forms for therapeutic use. The increasing prevalence of chronic diseases such as arthritis, cancer, and cardiovascular diseases, which require the use of prostaglandin-based medications is the important factor driving the growth of the prostaglandin market. For instance, as per the Rheumatoid Arthritis Network, in 2021, around 350 million people are living with arthritis globally.

Prostaglandin Market is expected to grow at a strong CAGR of 8% during the forecast period owing to increasing research efforts on the prostaglandin drug. For instance, the Federal University of Rio Grande do Sul conducted to compare the efficacy of topical application of PSLT and prostaglandin-like antihypertensive eye drops in the treatment of patients with ocular hypertension or glaucoma to reduce intraocular pressure and to reduce intraocular pressure using computerized perimetry and light therapy.

Based on type, the market is segmented into synthetic and natural. As per our analysis, the synthetic segment acquired a major share in 2021. Synthetic prostaglandins are typically used in the treatment of a variety of conditions, including ulcers, glaucoma, and erectile dysfunction. Synthetic prostaglandin can be produced in large quantities which is an important factor for the large share of the prostaglandin segment.

Based on the category, the market is segmented into human and veterinary. The veterinary segment is expected to grow with a higher CAGR in the prostaglandin market during the forecast period. The rising adoption of pets and livestock animals, along with the increasing prevalence of chronic disease among them is the major reason driving the growth of the veterinary segment.

Based on application, the market is segmented into cardiovascular, gynecological and obstetrical, ophthalmologic, and others. As per our analysis, the cardiovascular segment acquired a major share in 2021. The increasing prevalence of cardiac diseases is the main reason for the large share of cardiovascular diseases in the prostaglandin market. For instance, as per the World Health Organization (WHO), Cardiovascular disease (CVD) is the leading cause of death worldwide, claiming an estimated 17.9 million lives each year.

For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North American region held the dominant share of the prostaglandin market in 2021. This is mainly due to the presence of major economies such as the U.S., along with the presence of a large geriatric population in the region are the important factors for the market growth of the prostaglandin market in the region. For instance, as per the Administration for Community Living, In 2019, there were 54.1 million people aged 65 and over, including 30 million women and 24.1 million men in the U.S.

Some of the major players operating in the market include: Sanofi.; Cayman Chemical; YONSUNG Fine Chemicals Co.; Johnson Matthey; Chirogate International Inc.; Everlight Chemical Industrial Co.; Merck KGaA; Zhejiang Ausun Pharmaceutical Co., Ltd.; AspenBio; and Pfizer Inc.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Prostaglandin Market
  • 2.2. Research Methodology of the Prostaglandin Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL PROSTAGLANDIN MARKET COVID-19 IMPACT

6 GLOBAL PROSTAGLANDIN MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY TYPE

  • 7.1. Synthetic
  • 7.2. Natural

8 MARKET INSIGHTS BY CATEGORY

  • 8.1. Human
  • 8.2. Veterinary

9 MARKET INSIGHTS BY APPLICATION

  • 9.1. Cardiovascular
  • 9.2. Gynecological and Obstetrical
  • 9.3. Ophthalmologic
  • 9.4. Others

10 MARKET INSIGHTS BY REGION

  • 10.1. North America Prostaglandin Market
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe Prostaglandin Market
    • 10.2.1. Germany
    • 10.2.2. UK
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific Prostaglandin Market
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Australia
    • 10.3.5. South Korea
    • 10.3.6. Rest of APAC
  • 10.4. Rest of the World Prostaglandin Market

11 PROSTAGLANDIN MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 PROSTAGLANDIN MARKET OPPORTUNITIES

13 PROSTAGLANDIN MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 PRICING ANALYSIS

17 STRATEGIC INSIGHTS

18 COMPETITIVE SCENARIO

  • 18.1. Competitive Landscape
    • 18.1.1. Porters Fiver Forces Analysis

19 COMPANY PROFILED

  • 19.1. Sanofi
  • 19.2. Cayman Chemical
  • 19.3. YONSUNG Fine Chemicals Co.
  • 19.4. Johnson Matthey
  • 19.5. Chirogate International Inc.
  • 19.6. Everlight Chemical Industrial Co.
  • 19.7. Merck KGaA
  • 19.8. Zhejiang Ausun Pharmaceutical Co., Ltd.
  • 19.9. AspenBio
  • 19.10. Pfizer Inc.

20 DISCLAIMER